Hot Topics in Primary Care: Colorectal Cancer Screening.

J Fam Pract

Associate Head, Division of Gastroenterology, Associate Professor of Medicine, Cooper-Rowan Medical School, Camden, NJ, USA.

Published: December 2015

Colorectal cancer is a generally slow-growing cancer that is highly curable when detected at an early, localized stage. Dueto the lack of symptoms, even with advanced disease, screening is required to ensure cancers are detected early. Currently,however, only 3 in 5 people eligible for CRC screening undergo screening. Barriers vary somewhat by screening test and may differ in individual patients. Screening tests are generally more affordable due to recent changes in Medicare and private insurance coverage. Discussion with patients to identify barriers to screening makes it possible to select among the currently available invasive and noninvasive screening tests to determine the test that best meets the patient’s health needs with the overall goal of increasing screening for a preventable disease.

Download full-text PDF

Source

Publication Analysis

Top Keywords

screening
9
colorectal cancer
8
detected early
8
screening tests
8
hot topics
4
topics primary
4
primary care
4
care colorectal
4
cancer screening
4
screening colorectal
4

Similar Publications

Claudins as diagnostic tools and therapeutic targets-Glimpse of the horizon.

Cancer Treat Rev

January 2025

Gastrointestinal Unit, Department of Medicine, Royal Marsden Hospital, London and Surrey, UK. Electronic address:

Claudins (CLDNs) play a crucial and indispensable role as fundamental components within the structure of tight junctions. Due to the distinct and unique distribution pattern exhibited by CLDNs in both normal and malignant tissues, these proteins have garnered significant attention as pivotal targets for systemic anti-cancer therapy and as noteworthy diagnostic markers. This review provides a comprehensive and detailed elucidation of the fundamental understanding surrounding CLDNs, their intricate expression patterns, the potential role they play in cancer diagnosis and therapeutic potentials; all encapsulated within a succinct summary of the cutting-edge advancements and the information derived from various clinical trials.

View Article and Find Full Text PDF

Diagnostic clues in herpes encephalitis following radiation therapy.

J Neurol Sci

January 2025

The Gaffin Center for Neuro-Oncology, Sharett Institute of Oncology, Hadassah Medical Center, and Faculty of Medicine, The Hebrew University of Jerusalem, Israel. Electronic address:

Introduction: Herpes encephalitis is known to affect patients undergoing brain radiotherapy, but early diagnosis and treatment, the foremost determinants of disease outcome, remain challenging in this patient population. This can be due to attribution of symptoms to the brain tumor and radiation side effects, as well as patients' atypical clinical presentation. Here we sought to highlight pearls and pitfalls in the clinical course and diagnostic workup which may facilitate timely diagnosis and improve disease outcome.

View Article and Find Full Text PDF

The potential impact of one-carbon metabolism (OCM)-related B vitamins (vitamin B, B, B, and folate) on colorectal cancer survival warrants investigation but research is sparse. This cohort study examined the association between the prediagnostic dietary intakes of OCM-related B vitamins and colorectal cancer survival. A total of 2799 colorectal cancer patients from the Guangdong Colorectal Cancer Cohort, enrolled at baseline in 2010, were followed for mortality outcomes through 2023.

View Article and Find Full Text PDF

Objectives: It is estimated that up to 65 % of pwMS (people with multiple sclerosis) experience varying degrees of cognitive impairment, the most commonly affected domain being Information Processing Speed (IPS). As sleep disturbance is a predictor of detriments in IPS, the authors aimed to study the association between the severity of Restless Legs Syndrome (RLS) and Obstructive Sleep Apnea (OSA) symptoms with IPS in pwMS.

Methods: In a cross-sectional study, the authors enrolled people with relapsing-remitting and secondary progressive MS referred to the comprehensive MS center of Kashani Hospital in Isfahan, Iran.

View Article and Find Full Text PDF

Background: Patients with Crohn's disease face an elevated risk of colorectal cancer, in part due to underlying chronic inflammation. Biologic therapy is the mainstay of medical treatment; however, the impact of treatment on colorectal cancer-related outcomes remains unclear.

Objective: To investigate the association between prior exposure to biologic treatment and colorectal cancer-related outcomes in patients with underlying Crohn's disease.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!